Pharmapack Awards: Spotlight Shines on Safety
Winners of the 2012 Pharmapack Awards target needle safety, child resistance.
Packaging systems that promote safety were celebrated during the 2012 Pharmapack Awards, held during Pharmapack Europe February 15-16 in Paris. Recognized with the Pharmapack ‘Safety Device’ award was the K-Pack Surshield developed by Terumo; the Pharmapack ‘Child-Resistant’ Award went to the Child-Resistant Slider developed by Burgopak.
Designed for use with prefilled syringes, K-Pack Surshield consists of a hypodermic needle encapsulated by an integrated passive sharps protection feature. This protection mechanism is actuated during needle insertion and requires no activation, which means the needle is never exposed before, during, or after injection.
|Terumo's K-Pack Surshield|
The K-Pack Surshield system fits on prefilled syringes with standard 6% luer slip or 6% luer lock conical fittings. According to Terumo, its use does not require any changes in injection technique. In addition, activation of the safety feature does not require interaction with the syringe, nor does it affect dosing accuracy.
Terumo provides the K-Pack Surshield in individual rigid packages with tamper-evident color-coded labels. They can be handled in automated packaging processes such as bundling or insertion into secondary packaging of parenteral medication. Because it is intended to affix to the prefilled syringe at the point of use, it does not require additional assembly steps during packaging or manufacturing.
Terumo reports that given K-Pack Surshield’s status as a medical device, pharmaceutical companies do not need to invest in and validate additional assembly operations, which could save time to market.
In early February, Terumo Europe N.V. announced that its K-Pack Surshield needle had been selected for purchase by a global pharmaceutical company that plans to market the system with drugs used for hepatitis and liver transplantation. It also has reportedly expressed interest in K-Pack Surshield for other projects in its pipeline and in continued collaboration with Terumo.
|Burgopak's Child-Resistant Slider|
The Pharmapack ‘Child-Resistant’ Award was given to Burgopak for its Child-Resistant Slider. Based on the original Burgopak design, which keeps the blister pack, literature, and the outer carton permanently connected, the child-resistant slider features a pressure point locking system. When the user simultaneously pushes on two tabs and slides the pack open, the blister and literature appear at opposite ends of the package.
The pack is produced on Burgopak’s fully automated machinery and can be supplied to global pharmaceutical and healthcare companies.
According to Burgopak, the design has achieved the U.S. Consumer Product and Safety Commission’s F=1 child resistance and senior friendly effectiveness. This was achieved with impressive results: resistant effectiveness at a pass rate of 98% and senior adult use effectiveness at 95%, the company reports.
“Innovation is key to our success,” commented Tim Clarke, CEO of Burgopak, in a press release. “Working very closely with our customers, the Burgopak design team [is] constantly developing new pack formats. Gaining industry recognition by winning this award for the Burgopak CR Slider pack is a great achievement for the company.”
In May, Burgopak Healthcare & Technology will exhibit at the inaugural Pharmapack North America exhibition in Philadelphia.
The Pharmapack Awards acknowledged innovative packaging developments for drug, veterinary products and devices placed in the French market between December 2010 and 2011. To participate in the 2013 Pharmapack Awards and submit your innovative products launched to the market between December 2011 and December 2012, please send an e-mail to email@example.com or call +33 (0) 1 77 48 10 00. The 12th edition of Pharmapack Europe will be held on 13-14 February 2013 at the Grande Halle de la Villette in Paris, France.